89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 108 filers reported holding 89BIO INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,965,421 | -15.5% | 580,662 | +3.8% | 0.00% | 0.0% |
Q2 2023 | $10,605,027 | +585.4% | 559,632 | +450.9% | 0.00% | – |
Q1 2023 | $1,547,246 | +88.9% | 101,592 | +57.9% | 0.00% | – |
Q4 2022 | $818,870 | +105.7% | 64,326 | -6.3% | 0.00% | – |
Q3 2022 | $398,000 | +255.4% | 68,677 | +98.1% | 0.00% | – |
Q2 2022 | $112,000 | -69.8% | 34,676 | -64.8% | 0.00% | – |
Q1 2022 | $371,000 | -72.3% | 98,567 | -3.7% | 0.00% | – |
Q4 2021 | $1,339,000 | -33.8% | 102,390 | -0.9% | 0.00% | – |
Q3 2021 | $2,024,000 | -10.9% | 103,272 | -14.9% | 0.00% | – |
Q2 2021 | $2,271,000 | -20.8% | 121,414 | +0.2% | 0.00% | -100.0% |
Q1 2021 | $2,869,000 | -15.8% | 121,145 | -13.4% | 0.00% | 0.0% |
Q4 2020 | $3,409,000 | +17.1% | 139,885 | +23.4% | 0.00% | 0.0% |
Q3 2020 | $2,910,000 | +79.7% | 113,399 | +39.5% | 0.00% | – |
Q2 2020 | $1,619,000 | +49.4% | 81,267 | +89.2% | 0.00% | – |
Q1 2020 | $1,084,000 | +38.3% | 42,944 | +44.0% | 0.00% | – |
Q4 2019 | $784,000 | – | 29,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |